With a focus in the fast-growing world of next generation sequencing, Kailos Genetics, through its CLIA Services Laboratory, analyzes DNA for “genetic clues” associated with drug response, adverse response and diagnosis of disease. These clues enable physicians to proactively identify responders and non-responders to certain drug therapies, avoid serious adverse drug reactions that are genetically linked, and diagnose inherited and non-inherited diseases.

Brian Pollock
President & Chief Executive Officer

Troy Moore
Chief Scientific Officer

Randy C. Bachmeyer
Chief Technology Officer

David Kloske
VP of Informatics and Chief Technology Officer

Paul Owen
Chief Operations Officer

All resident associate companies on the HudsonAlpha campus are independently owned and operated.